Abstract
A review of the epidemiology sections of the prior chapters reveals that most people have had experience with alcohol, nicotine, and at least one illicit substance at some time in their lives.1,2 The consumption of these substances has many implications, especially for drug interactions when two or more pharmacological agents are taken at the same time. The situation becomes even more complex in individuals who are also consuming over-the-counter (OTC) medications and prescription drugs. Each substance has a potential for impacting on how other drugs are absorbed into the body, distributed throughout the tissues, metabolized, and how they impact on organs such as the brain.3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.
Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use front the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.
Schuckit, M. A. A clinical review of the use of anticonvulsive medications in persons with developmental disabilities. Developmental Disabilities: Clinical Insights 2, San Diego Regional Center for the Developmentally Disabled, 1998.
Daeppen, J.-B., Smith, T. L., Danko, G. P., et al. Clinical correlates of cigarette smoking and nicotine dependence in alcohol dependent men and women. Submitted to Alcohol and Alcoholism.
Salloum, I. M., Daley, D. C., Cornelius, J. R., et al. Disproportionate lethality in psychiatric patients with concurrent alcohol and cocaine abuse. American Journal of Psychiatry 153:953–955, 1996.
Weiss, R. D., Martinez-Roga, J., & Hufford, C. The significance of a coexisting opioid use disorder in cocaine dependence. American Journal of Drug and Alcohol Abuse 22:173–184, 1996.
Ross, J., Darke, S., & Hall, W. Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction 92:697–705, 1997.
Zukin, S. R., Sloboda, Z., & Javitt, D. C. Phencyclidine (PCP). In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 238–246.
Babe, K. S., & Serafin, W. E. Histamine, bradykinen, and their antagonists. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 581–600.
Bucholz, K. K., Hesselbrock, V. M., Heath, A. C., et al. Characterizing antisocial personality disorder symptoms in female and male relatives of alcoholics: A latent class analysis. Submitted to Addiction.
Myers, M. G., Stewart, D. G., & Brown, S. A. Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. American Journal of Psychiatry 155:479–485, 1998.
Kandel, D., & Yamaguchi, K. From beer to crack: Developmental patterns of drug involvement. American Journal of Public Health 53:851–855, 1993.
American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.
Schuckit, M. A., Daeppen, J.-B., Tipp, J. E., et al. The clinical course of alcohol-related problems in alcohol dependent and nonalcohol dependent drinking women and men. Journal of Studies on Alcohol 59:581–590, 1998.
Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.
Holdcraft, L. C., Iacono, W. G., & McGue, M. K. Antisocial personality disorder and depression in relation to alcoholism: A community-based sample. Journal of Studies on Alcohol 59:222–226, 1998.
Vaillant, G. Evidence that type I/type II dichotomy in alcoholism must be reexamined. Addiction 89:1049–1057, 1994.
Morrison, J., & Wickersham, P. Physicians disciplined by a state medical board. Journal of the American Medical Association 279:1889–1893, 1998.
Tanda, G., Pontieri, F. E., & DiChiara, G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common u 1 opioid receptor mechanism. Science 276: 2048–2050, 1997.
Tanaka, F., Shiratori, Y., Yokosuka, O., et al. Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism: Clinical and Experimental Research 21:596–601, 1997
Cowley, D. S., Roy-Byrne, P. P., Greenblatt, D. J., et al. Effect of diazepam on plasma γ-aminobutyric acid in sons of alcoholic fathers. Alcoholism: Clinical and Experimental Research 20:343–347, 1996.
Hoffman, P. L., & Tabakoff, B. Alcohol dependence: A commentary on mechanisms. Alcohol and Alcoholism 31:333–340, 1996.
Schuckit, M. A., Mazzanti, C., Smith, T. L., et al. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABAα6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study. Biological Psychiatry 45:647–651, 1999.
Parsian, A., & Cloninger, C. R. Human GABA-A receptor alpha 1 and alpha 3 subunits genes and alcoholism. Alcoholism: Clinical and Experimental Research 21:430–433, 1997.
Potokar, J., Coupland, N., Glue, P., et al. Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. Alchohol and Alcoholism 32:605–611, 1997.
Koob, G. F., & Roberts, A. J. Brain reward circuits in alcoholism. CNS Spectrums 4:23–37, 1999.
June, H. L., Grey, C., Warren-Reese, C., et al. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: Preclinical studies in ethanol-preferring and outbred Wistar rats. Alcoholism: Clinical and Experimental Research 22:2174–2185, 1998.
Sander, T., Gscheidel, N., Wendel, B., et al. Human-opioid receptor variation and alcohol dependence. Alcoholism: Clinical and Experimental Research 22:2108–2110, 1988.
Schuckit, M. A., & Smith, T. L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry 53:202–210, 1996.
Beirut, L. J., Dinwiddie, S. H., Begleiter, H., et al. Familial transmission of substance dependence: Alcohol, marijuana, cocaine, and habitual smoking. Archives of General Psychiatry 55:982–988, 1998.
Joseph, H., & Appel, P. Alcohol and methadone treatment: Consequences for the patient and program. American Journal of Drug and Alcohol Abuse 11:37–53, 1985.
Magura, S., Nwakeze, P. C., & Demsky, S. Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 93:51–60, 1998.
Grinspoon, L., & Bakalar, J. B. Marihuana. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 199–206.
Modell, J. G., & Mountry, J. M. Drinking and flying. New England Journal of Medicine 323:455–461, 1990.
Cherpitel, C. J. Alcohol and injuries resulting from violence: A review of emergency room studies. Addiction 59:157–165, 1994.
Russell, J. M., Newman, S. C., & Bland, R. C. Drug abuse and dependence. Acta Psychiatrica Scandinavica Supplementum 376:54–62, 1994.
Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.
McCance-Katz, E. F., Kosten, T. R., & Jatlow, P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—A multiple-dose study. Biological Psychiatry 44:250–259, 1998.
Reynaud, M., Petit, G., Potard, D., & Courty, P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 93:1385–1392, 1998.
Robins, L. N. Vietnam veterans’ rapid recovery from heroin addiction: A fluke or normal expectation? Addiction 88:1041–1054, 1993.
Albanese, M. J., Bartel, R. L., Bruno, R. E., et al. Comparisons of measures used to determine substance abuse in an inpatient psychiatric population. American Journal of Psychiatry 151:1077–1078, 1994.
Weinbroum, A. A., Flaishon, R., Sorkine, P., et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Safety 17:181–196, 1997.
Atkinson, J. H., Slater, M. A., Patterson, T. L., et al. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study. Pain 45:111–121, 1991.
Hubbard, J. R., Smith-Everett, A., & Khan, M. A. Alcohol and drug abuse in patients with physical disabilities. American Journal of Drug and Alcohol Abuse 22:215–231, 1996.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuckit, M.A. (2000). Multidrug Abuse and Dependence. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3232-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-3234-4
Online ISBN: 978-1-4757-3232-0
eBook Packages: Springer Book Archive